Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Repeated sugammadex usage in a patient with multiple sclerosis: a case report.
Sativex-induced neurobehavioral effects: causal or concausal? A practical advice!
Corrigendum: "High-Resolution Spectral Domain-Optical Coherence Tomography in Multiple Sclerosis, Part II - The Total Macular Volume. The First Follow-Up Study Over 2 Years".
Adherence to MRI protocol consensus guidelines in multiple sclerosis: An Australian multi-centre study.
Vitamin D in Systemic and Organ-Specific Autoimmune Diseases.
Quantitative MRI Analysis of the Brain after Twenty-Two Years of Neuromyelitis Optica Indicates Focal Tissue Damage.
Fine-Tuning of Regulatory T Cell Function: The Role of Calcium Signals and Naive Regulatory T Cells for Regulatory T Cell Deficiency in Multiple Sclerosis.
Quantitative PCR for Epstein-Barr virus DNA and RNA in multiple sclerosis.
Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis.
RORs in Autoimmune Disease.
Natalizumab Continued Past 24 Months Safely in MS
Brain-specific knockdown of miR-29 results in neuronal cell death and ataxia in mice.
Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies.
Neuropsychological rehabilitation does not improve cognitive performance but reduces perceived cognitive deficits in patients with multiple sclerosis: a randomised, controlled, multi-centre trial.
Can HPV immunisation cause ADEM? Two case reports and literature review.
Contribution of genome-wide association studies to scientific research: a pragmatic approach to evaluate their impact.
On the estimation and correction of bias in local atrophy estimations using example atrophy simulations.
Neuromyelitis Optica in Austria in 2011: To Bridge the Gap between Neuroepidemiological Research and Practice in a Study Population of 8.4 Million People.
Diagnosis and management of Neuro-Behçet's disease: international consensus recommendations.
Fatigue and its association with sleep disorders, depressive symptoms and anxiety in patients with multiple sclerosis.
Efficacy of lower fingolimod doses in the treatment of MS.
Exploring the role of microglia in mood disorders associated with experimental multiple sclerosis.
Neuropilin-1 mediates myeloid cell chemoattraction and influences retinal neuroimmune crosstalk.
DQB1*06:02-Associated Pathogenic Anti-Myelin Autoimmunity in Multiple Sclerosis-Like Disease: Potential Function of DQB1*06:02 as a Disease-Predisposing Allele.
Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder.

Pages